Literature DB >> 24242964

Quantitative immunofluorescent assay of full-length, recombinant CD4 in solution and mapping of its epitopes.

P F Tosi1, H Benoist, C Nicolau.   

Abstract

A specific, rapid, and sensitive method for the detection of CD4 in solution was developed using pairs of fluorescently stained monoclonal antibodies which do not cross-compete. The assay is quantitated by flow cytometry using Simply Cellular microbeads (SC beads) as the primary support for the first anti-CD4 mAb. This method uses the standard conditions for anti-CD4 monoclonal antibody binding, washing, detection, and quantitation by flow cytometry of the CD4 antigen either bound to the SC beads or expressed on the cell surface. The monoclonal antibody used (Leu 3a PE) is the standard reference used to evaluate the CD4 concentration. This method differs from ELISA techniques, which need an antigen standard curve and thus can be influenced by the quality and source of the antigen. This type of assay is also a procedure which enables determination of the level of oligomerization of the bound antigen. It can be used for any antigen to which monoclonal antibodies recognizing at least two distinct epitopes are available. The use of soluble or full-length CD4 derivatives as potential therapeutic agents against AIDS, would benefit from a precise quantitation of the CD4 molecules which still have their proper tertiary structure.

Entities:  

Year:  1991        PMID: 24242964     DOI: 10.1007/BF00865210

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  27 in total

1.  HIV infection is blocked in vitro by recombinant soluble CD4.

Authors:  R A Fisher; J M Bertonis; W Meier; V A Johnson; D S Costopoulos; T Liu; R Tizard; B D Walker; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

2.  Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

Authors:  A Traunecker; W Lüke; K Karjalainen
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

3.  A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.

Authors:  R E Hussey; N E Richardson; M Kowalski; N R Brown; H C Chang; R F Siliciano; T Dorfman; B Walker; J Sodroski; E L Reinherz
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

4.  Identification of the residues in human CD4 critical for the binding of HIV.

Authors:  J Arthos; K C Deen; M A Chaikin; J A Fornwald; G Sathe; Q J Sattentau; P R Clapham; R A Weiss; J S McDougal; C Pietropaolo
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

5.  Structural features of CD4 required for binding to HIV.

Authors:  C C Ibegbu; M S Kennedy; P J Maddon; K C Deen; D Hicks; R W Sweet; J S McDougal
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

6.  Structure and expression of the human and mouse T4 genes.

Authors:  P J Maddon; S M Molineaux; D E Maddon; K A Zimmerman; M Godfrey; F W Alt; L Chess; R Axel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens.

Authors:  W E Biddison; P E Rao; M A Talle; G Goldstein; S Shaw
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

8.  The T4 surface antigen is involved in the induction of helper function.

Authors:  L Rogozinski; A Bass; E Glickman; M A Talle; G Goldstein; J Wang; L Chess; Y Thomas
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

9.  Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques.

Authors:  M Watanabe; K A Reimann; P A DeLong; T Liu; R A Fisher; N L Letvin
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

10.  Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.

Authors:  B A Jameson; P E Rao; L I Kong; B H Hahn; G M Shaw; L E Hood; S B Kent
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.